A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder	Active, not recruiting	Phase 1	2026-05-15		NCT05653752

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioNTech SE	53
MediLink Therapeutics (Suzhou) Co., Ltd.	24

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BRCR Global	Plantation	United States	12
Fujian Cancer Hospital	Fuzhou	China	109
Hunan Cancer Hospital	Changsha	China	123
Jilin Provincial Cancer Hospital	Changchun	China	3
Karmanos Cancer Institute	Detroit	United States	153
Next Oncology-Dallas	Irving	United States	2
Next Oncology-Virginia	Fairfax	United States	1
Summit Cancer Center	Spokane Valley	United States	1
Taizhou Hospital of Zhejiang Province	Taizhou	China	7
The First Affiliated Hospital of Zhejiang University school of medicine	Hangzhou	China	18
The University of Texas MD Anderson Cancer Center	Houston	United States	207
UT Health East Texas HOPE Cancer Center	Tyler	United States	5
Zhejiang Cancer Hospital	Hangzhou	China	164